FQ
ONC

First Quadrant’s BeOne Medicines Ltd ONC Stock Holding History

First Quadrant’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,307
Closed -$246K – 728
2020
Q2 		$246K Buy
1,307
+1,121
+603% +$182K 0.03% 389
2020
Q1 		$23K Hold
186
– – ﹤0.01% 581
2019
Q4 		$31K Buy
+186
New +$30.9K ﹤0.01% 539

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

First Quadrant's ONC Position: Q3 2020 in Review

First Quadrant sold out of BeOne Medicines Ltd (ONC) in Q3 2020, closing a stake of 1,307 shares — an estimated $246K sold.

First Quadrant first reported a position in ONC in Q4 2019 and held it in 3 quarters. The position peaked at $246K in Q2 2020. 243 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

  • First Quadrant reported no remaining BeOne Medicines Ltd position as of Q3 2020 after selling out during the quarter.
  • First Quadrant sold 1,307 BeOne Medicines Ltd shares in Q3 2020, an estimated $246K.
  • First Quadrant first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 3 quarters.
  • First Quadrant's BeOne Medicines Ltd position peaked at $246K in Q2 2020.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on First Quadrant's 13F filing for Q3 2020, filed 28 Oct 2020.